Long-term survival after allogeneic-matched sibling PBSC transplantation with conditioning consisting of low-dose busilvex and fludarabine in a 3-year-old boy with ataxia-telangiectasia syndrome and ALL

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Ataxia Telangiectasia / drug therapy*
• Ataxia Telangiectasia / surgery*
• Busulfan / administration & dosage
• Child, Preschool
• Humans
• Male
• Peripheral Blood Stem Cell Transplantation / methods*
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery*
• Siblings
• Survival Analysis
• Tissue Donors
• Transplantation Conditioning / methods
• Vidarabine / administration & dosage
• Vidarabine / analogs & derivatives